Yutaka Sugiyama Selected Research

Yutaka Sugiyama Research Topics

Disease

8	Renal Cell Carcinoma (Grawitz Tumor) 03/2023 - 01/2004
7	Neoplasms (Cancer) 09/2022 - 11/2007
6	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 01/2018
6	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2018
2	Edema (Dropsy) 08/2022 - 03/2022
2	Glomerulonephritis 08/2022 - 01/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 05/2018 - 01/2004
1	Sjogren's Syndrome (Sjogren Syndrome) 03/2023
1	Carcinoma (Carcinomatosis) 09/2022
1	Ascites 08/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 08/2022
1	Hypertension (High Blood Pressure) 07/2022
1	Hematoma 07/2022
1	Hydronephrosis 07/2022
1	Capillary Leak Syndrome 03/2022
1	COVID-19 03/2022
1	Testicular Neoplasms (Testicular Cancer) 09/2021
1	Cellulitis 03/2020
1	Pemphigus (Pemphigus Vulgaris) 11/2019
1	Lupus Nephritis 01/2019
1	Disease Progression 01/2018
1	Proteinuria 12/2016
1	Overactive Urinary Bladder (Overactive Bladder) 01/2008
1	Pheochromocytoma 11/2007
1	Thrombosis (Thrombus) 11/2007
1	Nocturia 06/2007
1	Lower Urinary Tract Symptoms 06/2007
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2007
1	Diarrhea 05/2006
1	Hemolysis 05/2006
1	Polycythemia (Erythrocytosis) 05/2006
1	Atrophy 05/2006
1	Wounds and Injuries (Trauma) 05/2006
1	Body Weight (Weight, Body) 05/2006
1	Tuberculosis (Tuberculoses) 01/2004
1	Renal Tuberculosis 01/2004
1	Seasonal Allergic Rhinitis (Hay Fever) 02/2003

Drug/Important Bio-Agent (IBA)

4	Hormones (Hormone)IBA 12/2023 - 01/2021
3	NivolumabIBA 03/2023 - 03/2020
3	Androgen Receptors (Androgen Receptor)IBA 12/2022 - 03/2022
2	IpilimumabIBA 03/2023 - 11/2021
2	Immune Checkpoint InhibitorsIBA 03/2023 - 03/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2023 - 01/2019
2	Docetaxel (Taxotere)FDA Link 06/2022 - 03/2022
2	VaccinesIBA 03/2022 - 03/2020
2	Messenger RNA (mRNA)IBA 03/2022 - 03/2016
2	Tumor Biomarkers (Tumor Markers)IBA 09/2021 - 01/2018
1	AndrogensIBA 12/2023
1	bicalutamide (Casodex)FDA LinkGeneric 12/2023
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2023
1	Pilocarpine (Ocusert)FDA LinkGeneric 03/2023
1	SteroidsIBA 03/2023
1	Hemoglobins (Hemoglobin)IBA 12/2022
1	Alkaline PhosphataseIBA 12/2022
1	C-Reactive ProteinIBA 12/2022
1	DiureticsIBA 08/2022
1	Immunoglobulin G (IgG)IBA 08/2022
1	Rituximab (Mabthera)FDA Link 08/2022
1	yttrium-aluminum-garnetIBA 07/2022
1	HolmiumIBA 07/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2022
1	COVID-19 VaccinesIBA 03/2022
1	BNT162 VaccineIBA 03/2022
1	cabazitaxel FDA Link 03/2022
1	pembrolizumabIBA 12/2021
1	ParaffinIBA 12/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2021
1	Protein Subunit VaccinesIBA 03/2020
1	Peptides (Polypeptides)IBA 03/2020
1	Ganciclovir (Cytovene)FDA LinkGeneric 11/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	IntegrinsIBA 01/2019
1	AntigensIBA 05/2018
1	Interleukin-13IBA 12/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2016
1	HLA-DR Antigens (HLA-DR)IBA 03/2016
1	Solifenacin Succinate FDA Link 01/2008
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2008
1	Tamsulosin (Flomax)FDA LinkGeneric 06/2007
1	Serum AlbuminIBA 05/2006
1	CreatinineIBA 05/2006
1	TabletsIBA 02/2003
1	fexofenadine (Allegra)FDA LinkGeneric 02/2003

Therapy/Procedure

14	Therapeutics 03/2023 - 01/2004
4	Nephrectomy 03/2023 - 01/2004
3	Castration 06/2022 - 01/2021
3	Molecular Targeted Therapy 12/2021 - 05/2021
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2004
1	Immunotherapy 03/2023
1	Prostatectomy (Retropubic Prostatectomy) 09/2022
1	Stents 07/2022
1	Lasers (Laser) 07/2022
1	Orchiectomy (Orchidectomy) 09/2021
1	Cystectomy 05/2018
1	Adrenalectomy 11/2007
1	Aftercare (After-Treatment) 06/2007
1	Secondary Prevention 02/2003